Temporal trends, patient characteristics and hospital volume outcomes after transcoronary ablation of septal hypertrophy and septal myectomy for treatment of obstructive hypertrophic cardiomyopathy
Clinical Research in Cardiology · 2025
DOI: 10.1007/s00392-025-02773-7 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Research in Cardiology, 2025. Verfasst von Peter Moritz Becher und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Heart and Vascular Center Hamburg, Martinistrasse 52, 20246, Hamburg, Germany. m.becher@uke.de. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Heart Septum, Cardiac Surgical Procedures, Hospitals, High-Volume. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Hamburg-Eppendorf (UKE).
Abstract (Originalsprache)
Background
Hypertrophic obstructive cardiomyopathy (HOCM) is a hereditary cardiac disease associated with poor prognosis. Data on septal reduction therapy (SRT), including transcoronary ablation of septal hypertrophy (TASH) and surgical myectomy (SM), are limited. We aimed to evaluate temporal trends, patient characteristics, in-hospital outcomes, and the influence of institutional procedural volumes in a nationwide cohort.
Methods
We used nationwide administrative data from the German Federal Bureau of Statistics to identify HOCM patients undergoing TASH or SM between 2006 and 2019. Primary outcomes were in-hospital mortality and pacemaker implantation. Multivariable logistic regression assessed associations with institutional procedure volume.
Results
Among 8,514 SRT procedures, 5,293 (62.2%) were TASH and 3,221 (37.8%) SM. Annual volumes increased for both procedures between 2006 and 2019. SM patients were older (67.4 vs. 60.2 years), more often male, and had a higher comorbidity burden. Of all centers, 49.3% performed ≤ 20 SM per year, and 76.3% performed ≤ 20 TASH per year. Mitral surgery occurred in 36.1% of SM cases. In-hospital mortality was higher for SM than TASH (6.9% vs. 0.8%), while pacemaker implantation was more frequent with TASH (19.3% vs. 13.1%). Risk of in-hospital mortality after SM was higher in low-volume centers than in large centers (adjusted odds ratio 2.64; 95% confidence interval, 1.49–4.66).
Conclusion
SM was performed in older, more comorbid patiens and frequently included concomitant valve surgery. Higher in-hospital mortality at low-volume centers may partially reflect surgical complexity or case mix rather than volume alone. Our findings underscore the need for individualized referral strategies to experienced centers. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, University Heart and Vascular Center Hamburg, Martinistrasse 52, 20246, Hamburg, Germany. m.becher@uke.de.
- German Center for Cardiovascular Research (DZHK), Partner site Hamburg/Kiel/Lübeck, Hamburg, Germany. m.becher@uke.de.
- Department of Cardiology, University Heart and Vascular Center Hamburg, Martinistrasse 52, 20246, Hamburg, Germany.
- German Center for Cardiovascular Research (DZHK), Partner site Hamburg/Kiel/Lübeck, Hamburg, Germany.
- Center for Population Health Innovation (POINT), University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Cardiovascular Surgery, University Heart & Vascular Center Hamburg, Hamburg, Germany.
Förderung
- Universitätsklinikum Hamburg-Eppendorf (UKE)
Zitieren
APA
Becher, P. M., Brunner, F. J., Weimann, J., Remmel, M., Schrage, B., Patten, M., Detter, C., Reichenspurner, H., Kirchhof, P., Blankenberg, S., & Seiffert, M. (2025). Temporal trends, patient characteristics and hospital volume outcomes after transcoronary ablation of septal hypertrophy and septal myectomy for treatment of obstructive hypertrophic cardiomyopathy. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-025-02773-7
Vancouver
Becher PM, Brunner FJ, Weimann J, Remmel M, Schrage B, Patten M, et al. Temporal trends, patient characteristics and hospital volume outcomes after transcoronary ablation of septal hypertrophy and septal myectomy for treatment of obstructive hypertrophic cardiomyopathy. Clinical Research in Cardiology. 2025. doi:10.1007/s00392-025-02773-7
BibTeX
@article{Becher2025,
author = {Becher, Peter Moritz and Brunner, Fabian J and Weimann, Jessica and Remmel, Marko and Schrage, Benedikt and Patten, Monica and Detter, Christian and Reichenspurner, Hermann and Kirchhof, Paulus and Blankenberg, Stefan and Seiffert, Moritz},
title = {Temporal trends, patient characteristics and hospital volume outcomes after transcoronary ablation of septal hypertrophy and septal myectomy for treatment of obstructive hypertrophic cardiomyopathy},
journal = {Clinical Research in Cardiology},
year = {2025},
doi = {10.1007/s00392-025-02773-7}
}
EUVIMED